#USA #medical technology #Englewood #Zynex #Steven Dyson

Zynex Announces New Leadership with Steven Dyson as CEO

In a strategic shift aimed at revitalizing its growth trajectory, Zynex, Inc. has officially appointed Steven Dyson as its new Chief Executive Officer. This transition is set to take effect on August 18, 2025, and comes at a pivotal time for the innovative medical technology firm, which specializes in noninvasive medical devices designed for pain management and rehabilitation.

Founded in 1996, Zynex has been at the forefront of developing advanced medical solutions that enhance patient care. The company has gained recognition for its commitment to noninvasive technologies that improve the quality of life for individuals suffering from pain and monitoring needs.

Leadership Transition

Steven Dyson brings over 25 years of extensive experience in the medical technology sector to his new role. His previous leadership positions at Apax Partners, a global private equity firm, have honed his skills in acquiring, growing, and exiting a multitude of healthcare and medtech companies across various regions including Europe and India. Notably, Dyson's experience includes strategic roles at established companies like KCI (San Antonio, TX) and Neuraxpharm (Spain).

In his new role, Dyson will be based at Zynex's headquarters in Englewood, Colorado, while balancing life in London. He holds a Bachelor’s degree from Oxford University and a Ph.D. from Cambridge University, reflecting his strong academic background supporting his professional credibility.

Thomas Sandgaard, the current Chairman of the Board and the founder of Zynex, will remain deeply involved in the company’s strategies as he transitions from day-to-day operations to focusing on broader business and technology development. Sandgaard expressed enthusiasm about Dyson's leadership, stating, “I am excited to step back from day-to-day operations and continue contributing as Chairman. Steven brings deep expertise and a proven track record in the medical sector.”

Future Outlook

Dyson's appointment is particularly significant as Zynex aims to refocus its business strategy toward optimizing its payer mix and achieving accelerated growth. His proven leadership is expected to be instrumental in navigating the company through its next chapters, especially as the medical technology landscape evolves rapidly.

“I’m honored to join the Zynex team at this exciting time in the Company's history,” said Dyson following his appointment. He added, “The strong foundation built by Thomas over many years provides an excellent platform to deliver exceptional value for all our stakeholders.”

Zynex's existing product line includes various noninvasive medical devices aimed at pain management, rehabilitation, and patient monitoring. As healthcare becomes increasingly complex, Zynex is well-positioned to capitalize on growth opportunities, particularly in the realms of rehabilitation and remote patient monitoring.

A Step Toward Innovation

As Zynex embarks on this new journey under Dyson’s leadership, there is palpable excitement about the innovative pursuits that lie ahead. The company not only seeks to expand its product offerings but also aims to enhance the overall delivery of healthcare solutions that meet the needs of patients today.

This leadership change marks a milestone for Zynex, highlighting its commitment to not just maintaining a leader in the medical technology field but also innovating and adapting to meet the future's needs. In a time of unprecedented change in healthcare, the ability to pivot and embrace new strategies is critical, and Zynex is demonstrating its readiness to rise to the challenge.

As the company continues to develop innovative technologies, stakeholders can look forward to insights and developments that offer hope and relief to patients through noninvasive treatment methods. With Dyson at the helm, Zynex is set for a potential renaissance, bringing new advancements to the market that could benefit patients, providers, and partners alike.